Vault-13

MWG Management Ltd.

Washington, DC · CIK 1845151 · 13F filing filed 2025-11-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$81.3m reported value +56.7% vs Q2 2025
3positions
100.0%in top 10
1 new 0 added 0 reduced 1 sold out vs Q2 2025

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q3 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BEAM THERAPEUTICS INC COM BEAM BEAM 2,266,934 $55.0m67.66% 67.66% UnchangedShares held: Q4 2024 2.3m, Q1 2025 2.3m, Q2 2025 2.3m, Q3 2025 2.3m
2 LYELL IMMUNOPHARMA INC COM NEW LYEL LYEL 1,008,116 $16.4m20.13% 20.13% NewShares held: Q4 2024 0, Q1 2025 0, Q2 2025 0, Q3 2025 1.0m
3 PRIME MEDICINE INC COM PRME PRME 1,792,210 $9.9m12.21% 12.21% UnchangedShares held: Q4 2024 1.8m, Q1 2025 1.8m, Q2 2025 1.8m, Q3 2025 1.8m

Sold out since Q2 2025

SecurityTickerShares held beforeValue then
LYELL IMMUNOPHARMA INC 1,008,116 $8.9m1.0m shares